4166.TWO · OP
Taiwan · RS rating 22 · As of 2026-10-08
| Price | 24.20 TWD |
|---|---|
| 1-day change | +1.3% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 23 / 25 / 42 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 41 / 31 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | +28.9% |
| Distance from 52-week high | +13.9% |
| Market cap (USD) | $185.7M |